Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Baofeng Zhu, MD
Nantong First People's Hospital
Principal Investigator - Daoyuan Jing, MD
Jinhua Municipal Central Hospital
Principal Investigator - Dong Wu, M.D.
Peking Union Medical College Hospital
Study Chair - Hong Liu, MD
Lishui Municipal Central Hospital
Principal Investigator - Jianzhong Yang, MD
First Affiliated Hospital of Xinjiang Medical University
Principal Investigator - Mei Liu, M.D.
Affiliated Hospital of Qinghai University
Principal Investigator - Ming Sun, MD
Suqian People's Hospital
Principal Investigator - Na Wu, M.D.
Dengzhou People's Hospital
Principal Investigator - Ruifeng Wang, MD
Harbin Medical University
Principal Investigator - Shanshan Yu, M.D.
Guiyang Second People's Hospital
Principal Investigator - Shicheng Zheng, MD
West China Longquan Hospital Sichuan University
Principal Investigator - Wei Huang, MD
Wuxi Third People's Hospital
Principal Investigator - Xiao Fan, M.D.
Second People Hospital of Nanyang
Principal Investigator - Yan Shi, MD
The Second People's Hospital of Huai'an
Principal Investigator - Yanfeng Wang, M.D.
Liangxiang Hospital
Principal Investigator - Zhitao Lu, M.D.
Baoding Seventh Hospital
Principal Investigator - Zuoyan Wu, MD
Peking University Sixth Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Liangxiang Hospital
Beijing, Beijing Municipality, China
Recruiting - Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Recruiting - Peking University Sixth Hospital
Beijing, Beijing Municipality, China
Recruiting - Guiyang Second People'S Hospital
Guiyang, Guizhou, China
Recruiting - Baoding Seventh Hospital
Baoding, Hebei, China
Recruiting - Fourth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Recruiting - Dengzhou People'S Hospital
Dengzhou, Henan, China
Recruiting - Second People Hospital of Nanyang
Nanyang, Henan, China
Recruiting - the Second People'S Hospital of Huai'An
Huaian, Jiangsu, China
Recruiting - Nantong First People'S Hospital
Nantong, Jiangsu, China
Recruiting - Suqian People'S Hospital
Suqian, Jiangsu, China
Recruiting - Wuxi Third People'S Hospital
Wuxi, Jiangsu, China
Recruiting - Qinghai University Affiliated Hospital
Xining, Qinghai, China
Recruiting - West China Longquan Hospital Sichuan University
Chengdu, Sichuan, China
Recruiting - the First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
Recruiting - Jinhua Municipal Central Hospital
Jinhua, Zhejiang, China
Recruiting - Lishui Municipal Central Hospital
Lishui, Zhejiang, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Dec 2024
- Primary completion
- 1 Jun 2028
- Completion
- 1 Dec 2028
- Last update posted
- 15 Jun 2025
- Registered enrollment
- 1,504
- Registry id
- NCT03547232
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.